During the past decade, Renown Health conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renown Health" #1 sponsor was "Craig Anderson" with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Techfields Inc" with 1 trials sponsored, "Thomas L. Ortel" with 1 trials sponsored and "Veru Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renown Health" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The George Institute for Global Health, Australia" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Renown Health" are "Acute Ischemic Stroke Patients Receiving Reperfusion Therapy" (1 trials), "Breast Cancer" (1 trials), "Covid19" (1 trials), "Ischemic Stroke" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Renown Health" in a lesser frequency.

Most popular intervention types in "Renown Health" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Apixaban 2.5 MG" (1 trials), "Enobosarm & Abemaciclib Combo" (1 trials), "Guideline recommended standard monitoring" (1 trials) and "Low-intensity monitoring strategy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renown Health" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Renown Health". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Renown Health, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Renown Health, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".